Rheb-mTOR signaling pathway involved in tumor formation
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme - 55(2010), 1 vom: 11. Jan., Seite 11-7 |
| Sprache: |
Japanisch |
|---|
| Beteiligte Personen: |
Sato, Tatsuhiro [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 03.03.2010 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM194211789 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM194211789 | ||
| 003 | DE-627 | ||
| 005 | 20231223200247.0 | ||
| 007 | tu | ||
| 008 | 231223s2010 xx ||||| 00| ||jpn c | ||
| 028 | 5 | 2 | |a pubmed24n0647.xml |
| 035 | |a (DE-627)NLM194211789 | ||
| 035 | |a (NLM)20058701 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 100 | 1 | |a Sato, Tatsuhiro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rheb-mTOR signaling pathway involved in tumor formation |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 03.03.2010 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Amino Acids |2 NLM | |
| 650 | 7 | |a CRTC2 protein, human |2 NLM | |
| 650 | 7 | |a Insulin |2 NLM | |
| 650 | 7 | |a Intracellular Signaling Peptides and Proteins |2 NLM | |
| 650 | 7 | |a Multiprotein Complexes |2 NLM | |
| 650 | 7 | |a Neuropeptides |2 NLM | |
| 650 | 7 | |a Proteins |2 NLM | |
| 650 | 7 | |a Ras Homolog Enriched in Brain Protein |2 NLM | |
| 650 | 7 | |a Rheb protein, mouse |2 NLM | |
| 650 | 7 | |a Transcription Factors |2 NLM | |
| 650 | 7 | |a MTOR protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.1.1 |2 NLM | |
| 650 | 7 | |a mTOR protein, mouse |2 NLM | |
| 650 | 7 | |a EC 2.7.1.1 |2 NLM | |
| 650 | 7 | |a Mechanistic Target of Rapamycin Complex 1 |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Protein Serine-Threonine Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a TOR Serine-Threonine Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Monomeric GTP-Binding Proteins |2 NLM | |
| 650 | 7 | |a EC 3.6.5.2 |2 NLM | |
| 700 | 1 | |a Nakashima, Akio |e verfasserin |4 aut | |
| 700 | 1 | |a Tamanoi, Fuyuhiko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme |d 1961 |g 55(2010), 1 vom: 11. Jan., Seite 11-7 |w (DE-627)NLM000009865 |x 0039-9450 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2010 |g number:1 |g day:11 |g month:01 |g pages:11-7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2010 |e 1 |b 11 |c 01 |h 11-7 | ||